Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThames Wat.u 35 Regulatory News (AW14)

Share Price Information for Thames Wat.u 35 (AW14)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
AW14 Live PriceLast checked at - London Stock Exchange

Intraday Thames Wat.u 35 Share Chart

Liquidity Extension Update

12 Feb 2026 09:00

RNS Number : 7646S
Thames Water Utilities Limited
12 February 2026
 

Thames Water Utilities Limited

12 February 2026

 

Liquidity Extension Update relating to Additional Super Senior Issuer Funding

 

Background

Thames Water Utilities Limited ("TWUL") has so far drawn £1.426bn of the initial £1.5bn available under the super senior liquidity facility (the "Facility") entered into with its subsidiary, Thames Water Super Senior Issuer plc (the "Super Senior Issuer") in 2025.

In addition, TWUL and the Super Senior Issuer have the ability to raise a further £1.5bn in two tranches of £750m (augmented by any commitments under the Facility which are undrawn as a result of being deferred pursuant to the terms of the Second Consent Request[1] (the "Deferred Commitments")) (the "Accordion"), subject to satisfaction and/waiver of relevant conditions precedent. These include, amongst other things, that a supported lock-up agreement ("Supported LUA") is in place in respect of a second restructuring plan ("RP2") and that the CMA Reference Decision Condition[2] is satisfied.

TWUL continues to work closely with stakeholders to secure a market led solution, and following consultation with its creditors, hereby announces that the Super Senior Issuer will today launch a process to allocate c.£823m (the "Accordion Amount") comprising (i) commitments to the first £750m tranche of the Accordion; and (ii) Deferred Commitments and commitments which belong to Defaulting SSIS Creditors totalling c. £73m (the "Accordion Allocation Process").

The launch of the Accordion Allocation Process is the start of an administrative process to allocate the Accordion Amount only. Funding of the Accordion Amount remains subject to the satisfaction and/or waiver of relevant conditions precedent, some of which, as at today, have not yet been satisfied and/or waived in full and remain out of the Super Senior Issuer's control, including having a Supported LUA in respect of RP2.

Terms used but not otherwise defined have the meanings given to them in the Accordion Funding Letter (as defined below).

 

Accordion Allocation Process

Creditors who wish to participate in the Accordion Allocation Process are encouraged to review and complete the funding letter (the "Accordion Funding Letter") which will shortly be made available (together with other documents related to the Accordion Allocation Process) by Kroll Issuer Services Limited (the "Information Agent") at https://deals.is.kroll.com/thameswater-accordion.

The Accordion Funding Letter contains further details as to (i) creditors' entitlements to participate in the Accordion Allocation Process; (ii) how creditors can elect to participate in the Accordion Allocation Process; and (iii) how Accordion commitments will be allocated by the Super Senior Issuer.

An Eligible Additional Super Senior Funding Participant who elects to provide Accordion funding may still be allocated zero Accordion funding commitments if the entire available Accordion funding is taken up by Eligible Additional Super Senior Funding Participants who have a prior allocation right (in accordance with the terms of the Super Senior Issuer Intercreditor Agreement).

The Accordion Allocation Process has an election deadline of 5:00 p.m. (UK time) on 26 February 2026 by which time creditors must have submitted a completed Accordion Funding Letter and provided all required information, confirmations and documents in order to participate in the Accordion Allocation Process. Creditors should contact the Information Agent at thameswater@is.kroll.com with questions on how to complete and submit the Accordion Funding Letter.

STAKEHOLDERS ARE ENCOURAGED TO REVIEW THE ACCORDION ALLOCATION PROCESS DOCUMENTS IN DETAIL THEMSELVES (COPIES OF WHICH ARE AVAILABLE AT HTTPS://DEALS.IS.KROLL.COM/THAMESWATER-ACCORDION) AND SEEK THEIR OWN LEGAL AND FINANCIAL ADVICE[3] SHOULD THEY HAVE ANY QUERIES IN RELATION TO THEIR CONTENTS.

For further information

Investor enquiries

Fred Maroudas - Director of Corporate Finance debt.investorrelations@thameswater.co.uk

Media enquiries

Suvra Jans - Head of Media Relations 07747 640810

Suvra.jans@thameswater.co.uk

Alex Simmons thameswater@edelmansmithfield.com

LEI: 213800JKM5UQHFJOTZ25


[1] As such term is defined here: https://www.londonstockexchange.com/news-article/AW14/second-super-senior-funding-waiver-consent-request/17009385 

[2] This is a condition to the Accordion Facility and requires TWUL to have decided to ask its economic regulator, Ofwat, to refer its Final Determination to the Competition and Markets Authority (CMA) for a re-determination. TWUL announced its decision to do so on 14 February 2025 here: https://www.londonstockexchange.com/news-article/AW14/twul-referral-of-final-determination-to-cma/16899296. The most recent announcement in relation to the deferral of the making of the reference was made on 21 October 2025 and can be found here: https://www.londonstockexchange.com/news-article/AW14/cma-reference-deferral-update/17288549.

[3] Creditors can contact TWUL to receive details of existing creditor groups and their advisors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGIGDDUSBDGLD
12
Date   Source Headline
7th Jan 20254:24 pmRNSLiquidity Extension Update
27th Dec 20247:01 amRNSLiquidity Extension Update
27th Dec 20247:00 amRNSLiquidity Extension Update
20th Dec 20243:02 pmRNSTWUL - STID Proposal
19th Dec 20248:00 amRNSPR24 Final Determination
17th Dec 20246:13 pmRNSLiquidity Extension Update
17th Dec 20241:44 pmRNSLiquidity Extension Update
17th Dec 202410:00 amRNSLiquidity Extension Update
16th Dec 20244:57 pmRNSLiquidity Extension Update
13th Dec 20244:35 pmRNSLiquidity Extension Update
10th Dec 20247:19 amRNSInterim Financial Statements
10th Dec 20247:04 amRNSInterim Financial Statements
22nd Nov 202411:20 amRNSLiquidity Extension Update
18th Nov 20243:41 pmRNSSTID Proposal - Results Announcement
13th Nov 20247:00 amRNSLiquidity Extension Update
25th Oct 20243:14 pmRNSSTID Proposal - Notice of Bondholder Meetings
25th Oct 20243:12 pmRNSSTID Proposal Launch Announcement
25th Oct 20247:00 amRNSLiquidity Extension Update
30th Sep 202410:16 amRNSAnnual Financial Statements
20th Sep 20247:02 amRNSProcess Update
28th Aug 202412:28 pmRNSPR24 Draft Determination Response
31st Jul 20244:56 pmRNSS&P Ratings Action
24th Jul 202412:28 pmRNSMoody's ratings action
9th Jul 20247:00 amRNSAnnual Financial Report
9th Jul 20247:00 amRNSAnnual Financial Report
16th May 20247:00 amRNSDirector Change
22nd Apr 20247:00 amRNSPR24 Business Plan Update
28th Mar 20247:00 amRNSShareholder Funding Update
16th Feb 20248:00 amRNSCompany Information
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.